Post-marketing safety concern of PI3K inhibitors in the cancer therapies: an 8-year disproportionality analysis from the FDA Adverse Event Reporting System (Sep, 10.1080/14740338.2024.2387317, 2024)EXPERT OPINION ON DRUG SAFETYIF3.12024-10-220PRE
CD146 promotes malignant progression of breast phyllodes tumor through suppressing DCBLD2 degradation and activating the AKT pathwayCD146通过抑制DCBLD2降解和激活AKT通路促进乳腺叶状肿瘤的恶性进展CANCER COMMUNICATIONSIF24.92023-10-193OAAI
Breast Phyllodes Tumors Recruit and Repolarize Tumor-Associated Macrophages via Secreting CCL5 to Promote Malignant Progression, Which Can Be Inhibited by CCR5 Inhibition TherapyCLINICAL CANCER RESEARCHIF10.22019-07-01118OAAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向